Free Newsletter
Top Lilly exec plays secret sales agent
Here's a little secret about Eli Lilly's U.S. president Deidre Connelly (photo): She likes to go undercover. At a recent industry conference, Connelly confided that she sometimes goes on the road as a mild-mannered pharma rep. That way, she gets the on-the-ground skinny on what her sales force is up against. (Recently, she tried to strike up a conversation with a doc who'd ignored her; he demanded to know who she was. When he saw her title on her business card, he asked, "President? President of what?")
The main thrust of Connelly's speech, though, was about what she sees as a necessary evolution in pharma sales techniques. Reps can't be all about one-way communication, but need to promote give and take so they can actually help physicians solve problems. That sort of approach requires knowledge, and lots of it, so Connelly's in favor of building up specialty sales teams from within the company.
- read this post from Pharmalot
- read the report from Medical Marketing & Media
Related Articles:
In speech, Lilly CEO calls for drug monitoring. Report
No freebies? No entry for pharma reps. Report
Groups plan new fight to limit pharma-doctor ties. Report
Thinking through pharma bans. Editorial
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





